Clinical application of circulating tumor cells in breast cancer

Cellular Oncology

Volumn 37, Issue 1, 2014, Pages 9-15

  Broersen, Leonie H A ^a   Van Pelt, Gabi W ^a   Tollenaar, Rob A E M ^a   Mesker, Wilma E ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Breast cancer; Cancer stem cells; Circulating tumor cells; Genetic analysis; Molecular characterization; Personalized treatment

Indexed keywords

BREAST NEOPLASMS; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; HUMANS; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING; NEOPLASTIC STEM CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84894465321     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-013-0160-6     Document Type: Review

References (50)

1. E.S. Lianidou, A. Markou, Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges. Clin. Chem. 57(9), 1242-1255 (2011)
2. Y.F. Sun, X.R. Yang, J. Zhou, S.J. Qui, J. Fan, Y. Xu, Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance. J. Cancer Res. Clin. Oncol. 137, 1151-1173 (2011)
3. Y. Park, T. Kitahara, T. Urita, Y. Yoshida, R. Kato, Expected clinical applications of circulating tumor cells in breast cancer. World J. Clin. Oncol. 2(8), 303-310 (2011)
4. T. Fehm, V. Müller, C. Alix-Panabières, K. Pantel, Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevance. Breast Cancer Res. 10, S1 (2008)
5. M. Cristofanilli, G.T. Budd, M.J. Ellis, A. Stopeck, J. Matera, M.C. Miller et al., Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N. Engl. J. Med. 351(8), 781-791 (2004) (Pubitemid 39095313)
6. M.C. Miller, G.V. Doyle, L.W.M.M. Terstappen, Significance of circulating tumor cells detected by the cell search system in patients with metastatic breast colorectal and prostate cancer. J. Oncol. 2010, 617421 (2010)
7. S. Braun, F.D. Vogl, B. Naume, W. Janni, M.P. Osborne, R.C. Coombes et al., A pooled analysis of bone marrow micrometastasis in breast cancer. N. Engl. J. Med. 353(8), 793-802 (2005) (Pubitemid 41215488)
8. S. Kasimir-Bauer, Circulating tumor cells as markers for cancer risk assessment and treatment monitoring. Mol. Diagn. Ther. 13(4), 209-215 (2009)
9. M. Balic, H. Lin, A. Williams, R.H. Datar, R.J. Cote, Progress in circulating tumor cell capture and analysis: implications for cancer management. Expert. Rev. Mol. Diagn. 12(3), 303-312 (2012)
10. S.E. Singletary, C. Allred, P. Ashley, L.W. Bassett, D. Berry, K.I. Bland et al., Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual. Surg. Clin. N. Am. 83(4), 803-819 (2003) (Pubitemid 36841911)
11. J.E. Lang, K. Mosalpuria, M. Cristofanilli, S. Krishnamurthy, J. Reuben, B. Singh et al., HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer. Breast Cancer Res. Treat. 113, 501-507 (2009)
12. N. Harbeck, C. Thomssen, A new look at node-negative breast cancer. Oncologist 16, 51-60 (2011)
13. M.M. Reinholz, K.A. Kitzmann, K. Tenner, D. Hillman, A.C. Dueck, T.J. Hobday et al., Cytokeratin-19 and mammaglobin gene expression in circulating tumor cells from metastatic breast cancer patients enrolled in North Central cancer treatment group trials, N0234/336/436/437. Clin. Cancer Res. 17(22), 7183-7193 (2011)
14. H.M. Parsons, T.M. Tuttle, K.M. Kuntz, J.W. Begun, P.M. McGovern, B.A. Virnig, Association between lymph node evaluation for colon cancer and node positivity over the past 20 years. JAMA 306(10), 1089-1097 (2011)
15. V. Mikulová, K. Kološtová, T. Zima, Methods for detection of circulating tumour cells and their clinical value in cancer patients. Folia Biol. 57, 151-161 (2011)
16. B. Mostert, A.M. Sieuwerts, J.W.M. Martens, S. Sleijfer, Diagnostic applications of cell-free and tumor cell-associated miRNAs in cancer patients. Expert. Rev. Mol. Diagn. 11(3), 259-275 (2011)
17. G. Deng, M. Herrler, D. Burgess, E. Manna, D. Krag, J.F. Burke, Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly the sensitivity for circulating tumor cell detection in metastatic breast cancer patients. Breast Cancer Res. 10, R69 (2008)
18. M. Ignatiadis, V. Georgoulias, D. Mavroudis, Circulating tumor cells in breast cancer. Curr. Opin. Obstet. Gynecol. 20, 55-60 (2008)
19. H. Lin, M. Balic, S. Zheng, R. Datar, R.J. Cote, Disseminated and circulating tumor cells: role in effective cancer management. Crit. Rev. Oncol. Hematol. 77, 1-11 (2011)
20. F. Nolé, E. Munzone, L. Zorzino, I. Minchella, M. Salvatici, E. Botteri et al., Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications. Ann. Oncol. 19, 891-897 (2008) (Pubitemid 351627303)
21. E. Botteri, M.T. Sandri, V. Bagnardi, E. Munzone, L. Zorzino, N. Rotmensz et al., Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer. Breast Cancer Res. Treat. 122, 211-217 (2010)
22. A. Gervasoni, R.M. Monasterio Muñoz, G.S. Wengler, A. Rizzi, A. Zaniboni, O. Parolini, Molecular signature detection of circulating tumor cells using a panel of selected genes. Cancer Lett. 263, 267-279 (2008)
23. F. Farace, C. Massard, N. Vimond, F. Drusch, N. Jacques, F. Billiot et al., A direct comparison of Cell Search and ISET for circulating tumour-cell detection in patients with metastatic carcinomas. Br. J. Cancer 105, 847-853 (2011)
24. T. Tanaka, T. Ishikawa, K. Numayama-Tsuruta, Y. Imai, H. Ueno, T. Yoshimoto et al., Inertial migration of cancer cells in blood flow in microchannels. Biomed. Microdevices 14, 25-33 (2012)
25. W.E. Mesker, H. Vrolijk, W.C.R. Sloos, R.A.E.M. Tollenaar, H.J. Tanke, Detection of tumor cells in bone marrow, peripheral blood and lymph nodes by automated imaging devices. Cell. Oncol. 28, 141-150 (2006) (Pubitemid 44427397)
26. R.E. Payne, F. Wang, N. Su, J. Krell, A. Zebrowski, E. Yagüe et al., Viable circulating tumour cell detection using multiplex RNA in situ hybridisation predicts progression-free survival in metastatic breast cancer patients. Br. J. Cancer 106, 1790-1797 (2012)
27. J. Jacob, J. Krell, L. Castellano, L.R. Jiao, J. Stebbing, A.E. Frampton, Determination of cut-offs for circulating tumor cell measurement in metastatic cancer. Expert. Rev. Anticancer. Ther. 11(9), 1345-1350 (2011)
28. F.C. Bidard, C. Mathiot, S. Delaloge, E. Brain, S. Giachetti, P. De Cremoux et al., Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer. Ann. Oncol. 21, 729-733 (2010)
29. J.Y. Pierga, F.C. Bidard, C. Mathiot, E. Brain, S. Delaloge, S. Giachetti et al., Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial. Clin. Cancer Res. 14, 7004-7010 (2008)
30. H. Yagata, S. Nakamura, M. Toi, H. Bando, S. Ohno, A. Kataoka, Evaluation of circulating tumor cells in patients with breast cancer: multi-institutional clinical trial in Japan. Int. J. Clin. Oncol. 13, 252-256 (2008) (Pubitemid 351871893)
31. F.A.W. Coumans, S.T. Ligthart, J.W. Uhr, L.W. Terstappen, Challenges in the enumeration and phenotyping of CTC. Clin. Cancer Res. 18(20), 5711-5718 (2012)
32. 18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastates from breast cancer. J. Nucl. Med. 51, 1213-1218 (2010)
33. I. Van der Auwera, D. Peeters, I.H. Benoy, H.J. Elst, S.J. Van Laere, A. Prové et al., Circulating tumour cell detection: a direct comparison between the Cell Search system, the Adna test and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer. Br. J. Cancer 102, 276-284 (2010)
34. F.C. Bidard, D. Hajage, T. Bachelot, S. Delaloge, E. Brain, M. Campone et al., Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study. Breast Cancer Res. 14, R29 (2012)
35. M.T. Sandri, L. Zorzino, M.C. Cassatella, F. Bassi, A. Luini, C. Casadio et al., Changes in circulating tumor cell detection in patients with localized breast cancer before and after surgery. Ann. Surg. Oncol. 17, 1539-1545 (2010)
36. J.Á. García-Sáenz, M. Martín, M.L. Maestro, M. Vidaurreta, S. Veganzones, S. Rafael et al., Circulating tumour cells in locally advanced breast cancer. Clin. Transl. Oncol. 11, 544-547 (2009)
37. 18F]fluorodeoxyglucose positron emission tomography/computed tomography, cancer antigen 27.29, and circulating tumor cell testing in metastatic breast cancer. Clin. Breast Cancer 8(4), 357-361 (2008)
38. N. Hayashi, H. Yamauchi, Role of circulating tumor cells and disseminated tumor cells in primary breast cancer. Breast Cancer 19, 110-117 (2012)
39. L. Wang, Y. Wang, Y. Liu, M. Cheng, X. Wu, H. Wei, Flow cytometric analysis of CK19 expression in the peripheral blood of breast carcinoma patients: relevance for circulating tumor cell detection. J. Exp. Clin. Cancer Res. 28, 57 (2009)
40. L. Bertazza, S. Mocellin, D. Nitti, Circulating tumor cells in solid cancer: tumor marker of clinical relevance? Curr. Oncol. Rep. 10, 137-146 (2008) (Pubitemid 351395474)
41. M. Gerlinger, A.J. Rowan, S. Horswell, J. Larkin, D. Endesfelder, E. Gronroos et al., Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366(10), 883-892 (2012)
42. P. Kim, X. Liu, T. Lee, L. Liu, R. Barham, R. Kirkland et al., Highly sensitive proximity mediated immunoassay reveals HER2 status conversion in the circulating tumor cells of metastatic breast cancer patiënts. Proteome Sci. 9, 75 (2011)
43. T.J. Molloy, P. Roepman, B. Naume, L.J. Van't Veer, A prognostic gene expression profile that predicts circulating tumor cell presence in breast cancer patients. PLoS ONE 7(2), 32426 (2012)
44. R. Saldova, J.M. Reuben, U.M. Abd Hamid, P.M. Rudd, M. Cristofanilli, Levels of specific serum N-glycans identify breast cancer patients with higher circulating tumor cell counts. Ann. Oncol. 22, 1113-1119 (2011)
45. M. Kakarala, M.S. Wicha, Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy. J. Clin. Oncol. 26(17), 2813-2820 (2008)
46. A. Giordano, H. Gao, S. Anfossi, E. Cohen, M. Mego, B.N. Lee et al., Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer. Mol. Cancer Ther. 11(11), 2526-2534 (2012)
47. J. Chen, Z.L. Chen, Technology update for the sorting and identification of breast cancer stem cells. Chin. J. Cancer. 29(3), 265-269 (2010)
48. E. Charafe-Jauffret, F. Monville, C. Ginestier, G. Dontu, D. Birnbaum, M.S. Wicha, Cancer stem cells in breast: current opinion and future challenges. Pathobiology 75(2), 75-84 (2008) (Pubitemid 351820725)
49. M.P. Ablett, J.K. Singh, R.B. Clarke, Stem cells in breast tumours: are they ready for the clinic? Eur. J. Cancer 48, 2104-2116 (2012)
50. Xu D, Xu H, Ren Y, Liu C, Wang X, Zhang H, et al. Cancer stem cell-related gene periostin: a novel prognostic marker for breast cancer. PLoS ONE 7(10), (2012)